Medovex Corporation Announces Columbia Regulatory Approval and Issuance of Two New US Patent Approvals
MEDOVEX CORP COMMON (MDVX)
US:NASDAQ Investor Relations:
ir.medovex.com
Company Research
Source: GlobeNewswire
ATLANTA, April 05, 2018 (GLOBE NEWSWIRE) -- Medovex Corp. (OTCQB:MDVX) ("Medovex" or the "Company"), the developer of the DenerveX® System, a new and novel device designed for enduring relief of Facet Joint Syndrome related to chronic back pain, a non-addictive, non-opioid drug alternative capable of restoring a patient to a more normal and active lifestyle, today announced that the Company has received Columbia regulatory approval for its DenerveX System as well as being issued two US patents and a trademark. The Company’s INVIMA product approval for Colombia was granted for a period of 10 years, allowing the Company immediate product release to its first two signed distributors, located in Medellin and in Bogota. Additionally, the Company has been issued two US patents and a trademark covering the EU for “Rotacapsulation”. Patent No: US D810,290S Surgical Portal DriverPatent No: US 9,883,882 Minimally Invasive Methods for Spinal Facet Therapy to alleviate pain and associa
Show less
Read more
Impact Snapshot
Event Time:
MDVX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MDVX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MDVX alerts
High impacting MEDOVEX CORP COMMON news events
Weekly update
A roundup of the hottest topics